SCHEMBL8710833

SCHEMBL8710833

CC(C)OCCCNC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
GAA P10253 1/20 0.54
TSHR P16473 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 2/20 0.50
KMT2A Q03164 2/20 0.50
HTT P42858 1/20 0.50
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PAX8 Q06710 1/20 0.48
CYP3A4 P08684 1/20 0.46
RAB9A P51151 1/20 0.46
TP53 P04637 1/20 0.46
PKM P14618 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18596695 0.92 ALDH1A1 (0.54) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL3555994 0.87 EPHX2 (0.47) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL885125 0.83 ALDH1A1 (0.62) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL12543513 0.82 ALDH1A1 (0.61) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL2303769 0.82 ALDH1A1 (0.61) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL19808633 0.82 ALDH1A1 (0.61) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL1543240 0.80 ALDH1A1 (0.42) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL13853552 0.80 ALDH1A1 (0.59) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL12448213 0.80 ALDH1A1 (0.59) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2
SCHEMBL6358125 0.80 KMT2A (0.59) ALDH1A1GAATSHRL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593079-B1 MENTHYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES SYMRISE AG (DE) 2016-11-16 EP disclosed
US-9060949-B2 Menthyl carbamate compounds as skin and/or hair lightening actives SYMRISE AG (DE) 2015-06-23 US disclosed
US-20130129646-A1 MENTHYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES SYMRISE AG (DE) 2013-05-23 US disclosed
EP-0885239-A1 NOVEL STEROID CARBAMATES AS POTENTIATING AGENTS Batra, Satish (SE) 1998-12-23 EP disclosed
WO-1997027211-A1 NOVEL STEROID CARBAMATES AS POTENTIATING AGENTS BATRA SATISH (SE) 1997-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130129646-A1 MENTHYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES TYR, CRAT, SUCLG1 ALDH1A1 160/4885GAA 4041/4885TSHR 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.